Earlier this year, a group of health policy researchers uncovered a potential unintended consequence of disclosing drugmaker payments to doctors.
Increased transparency diminished Americans' trust in the physician profession, regardless of whether or not their own doctor actually took industry money, survey results showed.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,